ZNF697
geneOn this page
Also known as MGC45731
Summary
ZNF697 (zinc finger protein 697, HGNC:32034) is a protein-coding gene on chromosome 1p12, encoding Zinc finger protein 697 (Q5TEC3). RNA-interacting protein with a high number of miRNA targets.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus.
Source: NCBI Gene 90874 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 98 total
- MANE Select transcript:
NM_001080470
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32034 |
| Approved symbol | ZNF697 |
| Name | zinc finger protein 697 |
| Location | 1p12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC45731 |
| Ensembl gene | ENSG00000143067 |
| Ensembl biotype | protein_coding |
| OMIM | 620981 |
| Entrez | 90874 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000421812, ENST00000887271
RefSeq mRNA: 1 — MANE Select: NM_001080470
NM_001080470
CCDS: CCDS44202
Canonical transcript exons
ENST00000421812 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001689226 | 119647691 | 119648266 |
| ENSE00001733724 | 119625875 | 119626137 |
| ENSE00002177000 | 119619377 | 119624116 |
Expression profiles
Bgee: expression breadth ubiquitous, 207 present calls, max score 90.11.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.8947 / max 101.2652, expressed in 1641 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 14080 | 8.2897 | 1628 |
| 14079 | 0.6050 | 346 |
Top tissues by expression
239 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cartilage tissue | UBERON:0002418 | 90.11 | gold quality |
| kidney epithelium | UBERON:0004819 | 87.38 | gold quality |
| cortical plate | UBERON:0005343 | 86.09 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.86 | gold quality |
| pancreatic ductal cell | CL:0002079 | 81.10 | silver quality |
| placenta | UBERON:0001987 | 80.98 | gold quality |
| tibialis anterior | UBERON:0001385 | 80.68 | silver quality |
| left ventricle myocardium | UBERON:0006566 | 80.29 | silver quality |
| islet of Langerhans | UBERON:0000006 | 80.22 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 80.11 | silver quality |
| ganglionic eminence | UBERON:0004023 | 79.44 | gold quality |
| stromal cell of endometrium | CL:0002255 | 78.92 | gold quality |
| parotid gland | UBERON:0001831 | 78.87 | gold quality |
| secondary oocyte | CL:0000655 | 77.03 | gold quality |
| visceral pleura | UBERON:0002401 | 76.93 | gold quality |
| skin of hip | UBERON:0001554 | 76.38 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.92 | gold quality |
| ileal mucosa | UBERON:0000331 | 75.80 | gold quality |
| kidney | UBERON:0002113 | 75.16 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 74.80 | silver quality |
| myocardium | UBERON:0002349 | 74.77 | silver quality |
| parietal pleura | UBERON:0002400 | 74.33 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 74.26 | gold quality |
| metanephros | UBERON:0000081 | 74.13 | gold quality |
| monocyte | CL:0000576 | 73.86 | gold quality |
| oocyte | CL:0000023 | 73.37 | gold quality |
| leukocyte | CL:0000738 | 73.33 | gold quality |
| sperm | CL:0000019 | 73.14 | silver quality |
| tendon of biceps brachii | UBERON:0008188 | 72.80 | silver quality |
| metanephros cortex | UBERON:0010533 | 72.48 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.58 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
144 targeting ZNF697, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-10401-5P | 99.99 | 65.79 | 948 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-4487 | 99.96 | 64.58 | 1252 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp697 | ENSMUSG00000050064 |
| rattus_norvegicus | Zfp697 | ENSRNOG00000065357 |
Paralogs (51): WIZ (ENSG00000011451), ZNF416 (ENSG00000083817), MYNN (ENSG00000085274), PRDM4 (ENSG00000110851), PRDM2 (ENSG00000116731), ZBTB17 (ENSG00000116809), ZNF644 (ENSG00000122482), GZF1 (ENSG00000125812), ZNF426 (ENSG00000130818), ZNF287 (ENSG00000141040), ZNF687 (ENSG00000143373), ZNF214 (ENSG00000149050), ZNF547 (ENSG00000152433), ZNF776 (ENSG00000152443), ZNF230 (ENSG00000159882), ZNF222 (ENSG00000159885), ZNF233 (ENSG00000159915), ZNF333 (ENSG00000160961), ZNF319 (ENSG00000166188), ZNF592 (ENSG00000166716), ZNF646 (ENSG00000167395), ZNF507 (ENSG00000168813), ZNF768 (ENSG00000169957), ZNF417 (ENSG00000173480), ZNF408 (ENSG00000175213), ZBTB41 (ENSG00000177888), ZNF223 (ENSG00000178386), ZNF852 (ENSG00000178917), ZNF784 (ENSG00000179922), ZNF572 (ENSG00000180938), ZNF707 (ENSG00000181135), ZNF746 (ENSG00000181220), ZNF467 (ENSG00000181444), ZNF530 (ENSG00000183647), ZNF17 (ENSG00000186272), ZNF527 (ENSG00000189164), ZKSCAN7 (ENSG00000196345), ZNF34 (ENSG00000196378), ZNF774 (ENSG00000196391), ZNF777 (ENSG00000196453)
Protein
Protein identifiers
Zinc finger protein 697 — Q5TEC3 (reviewed: Q5TEC3)
All UniProt accessions (1): Q5TEC3
UniProt curated annotations — full annotation on UniProt →
Function. RNA-interacting protein with a high number of miRNA targets. Acts as a damage-induced regulator of muscle remodeling by mediating the interferon gamma response in muscle cells.
Subcellular location. Nucleus.
Induction. Expression is transiently elevated during intense exercise and recovery from muscle atrophy or injury.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_001073939* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050331 | Zinc_finger_PRDM4/PRDM1/PRDM14 | Family |
Pfam: PF00096
UniProt features (19 total): zinc finger region 11, compositionally biased region 4, chain 1, region of interest 1, cross-link 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5TEC3-F1 | 65.99 | 0.07 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 2
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 102 (showing top):
GOBP_RESPONSE_TO_PEPTIDE, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, DODD_NASOPHARYNGEAL_CARCINOMA_UP, chr1p12, GOBP_RESPONSE_TO_TYPE_II_INTERFERON, GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP, MASSARWEH_TAMOXIFEN_RESISTANCE_UP, GOMF_MIRNA_BINDING, YOSHIMURA_MAPK8_TARGETS_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP, PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, CSR_EARLY_UP.V1_UP, GOMF_REGULATORY_RNA_BINDING
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), response to type II interferon (GO:0034341)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), miRNA binding (GO:0035198), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| response to cytokine | 1 |
| innate immune response | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| regulatory RNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
244 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF697 | B3KSW5 | B3KSW5 | 542 |
| ZNF697 | GAPVD1 | Q14C86 | 480 |
| ZNF697 | ZFYVE16 | Q7Z3T8 | 476 |
| ZNF697 | Q6IQ01 | Q6IQ01 | 448 |
| ZNF697 | ANKRA2 | Q9H9E1 | 420 |
| ZNF697 | ZBTB21 | Q9ULJ3 | 412 |
| ZNF697 | ZZZ3 | Q8IYH5 | 410 |
| ZNF697 | ZNF608 | Q9ULD9 | 407 |
| ZNF697 | MT1M | Q8N339 | 353 |
| ZNF697 | MT1H | P80294 | 325 |
| ZNF697 | INKA1 | Q96EL1 | 323 |
| ZNF697 | ADAM30 | Q9UKF2 | 312 |
| ZNF697 | PPP1R3F | Q6ZSY5 | 306 |
| ZNF697 | ZBED4 | O75132 | 306 |
| ZNF697 | SLC15A5 | A6NIM6 | 305 |
IntAct
21 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF697 | DNM2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF697 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| ZNF697 | GRN | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF697 | WFS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF697 | GDAP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HTT | ZNF697 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCL1 | ZNF697 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SCRIB | C1orf226 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (16): ZNF697 (Two-hybrid), ZNF697 (Two-hybrid), ZNF697 (Two-hybrid), KRT40 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-5 (Two-hybrid), KRTAP10-8 (Two-hybrid), KRTAP10-3 (Two-hybrid), ZNF697 (Two-hybrid), ZNF697 (Affinity Capture-MS), ZNF697 (Affinity Capture-RNA), ZNF697 (Affinity Capture-MS), ZNF697 (Affinity Capture-MS), ZNF697 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A2CE44, A6NFI3, A6NM28, A8K8V0, O15370, O70218, O95201, P0CJ78, P10075, P10754, P28698, P70338, Q04890, Q07120, Q14V87, Q19A40, Q569E7, Q58DK7, Q5DWN0, Q5FWU5, Q5RJR4, Q5T619, Q5TEC3, Q6DD87, Q6IQX8, Q6PD29, Q6PGE4, Q6ZMY9, Q7Z7K2, Q80VM4, Q8BIF9, Q8JZL0, Q8N8E2, Q8NAF0, Q8NCA9, Q8TD94, Q8WUU4, Q96C55, Q96H86, Q96MX3
Diamond homologs: P0CG23, Q3US17, Q569E7, Q5TEC3, Q96MX3, P18714, P18715, P18718, P18724, P18725, P18731, P18735, P18737, P18738, P18740, P18747, P52742, Q01611, Q02085, Q3MJ62, Q6A085, Q6DD87, Q7L3S4, Q7TNU6, Q8BIF9, Q8BJ90, Q9UC06, Q9UEG4, A1L1L7, A1YEV9, A1YG26, A2T712, A2T7L7, O60304, P18716, P18719, P18729, P18730, P18736, P18741
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
98 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 89 |
| Likely benign | 6 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
810 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:119624113:CCCT:C | acceptor_gain | 1.0000 |
| 1:119624114:CCTC:C | acceptor_gain | 1.0000 |
| 1:119624117:C:CC | acceptor_gain | 1.0000 |
| 1:119625870:CTCAC:C | donor_loss | 1.0000 |
| 1:119625872:CACC:C | donor_loss | 1.0000 |
| 1:119625873:ACCTG:A | donor_loss | 1.0000 |
| 1:119626102:C:T | acceptor_gain | 1.0000 |
| 1:119626145:A:T | acceptor_gain | 1.0000 |
| 1:119636229:AG:A | donor_gain | 1.0000 |
| 1:119624112:CCCCT:C | acceptor_gain | 0.9900 |
| 1:119624113:CCCTC:C | acceptor_gain | 0.9900 |
| 1:119624114:CCT:C | acceptor_gain | 0.9900 |
| 1:119624115:CT:C | acceptor_gain | 0.9900 |
| 1:119624115:CTC:C | acceptor_gain | 0.9900 |
| 1:119624116:TC:T | acceptor_loss | 0.9900 |
| 1:119624116:TCT:T | acceptor_gain | 0.9900 |
| 1:119624117:C:A | acceptor_gain | 0.9900 |
| 1:119624117:CTGCA:C | acceptor_loss | 0.9900 |
| 1:119624123:C:CT | acceptor_gain | 0.9900 |
| 1:119624124:A:T | acceptor_gain | 0.9900 |
| 1:119625899:C:A | donor_gain | 0.9900 |
| 1:119626102:C:CT | acceptor_gain | 0.9900 |
| 1:119626103:A:T | acceptor_gain | 0.9900 |
| 1:119626135:TCC:T | acceptor_gain | 0.9900 |
| 1:119626136:CC:C | acceptor_gain | 0.9900 |
| 1:119626136:CCC:C | acceptor_gain | 0.9900 |
| 1:119626137:CC:C | acceptor_gain | 0.9900 |
| 1:119626138:C:CC | acceptor_gain | 0.9900 |
| 1:119626144:C:CT | acceptor_gain | 0.9900 |
| 1:119626144:C:T | acceptor_gain | 0.9900 |
AlphaMissense
3629 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:119622837:A:C | F502L | 1.000 |
| 1:119622837:A:T | F502L | 1.000 |
| 1:119622839:A:G | F502L | 1.000 |
| 1:119622889:C:G | R485P | 1.000 |
| 1:119622921:G:C | F474L | 1.000 |
| 1:119622921:G:T | F474L | 1.000 |
| 1:119622923:A:G | F474L | 1.000 |
| 1:119623005:G:C | F446L | 1.000 |
| 1:119623005:G:T | F446L | 1.000 |
| 1:119623007:A:G | F446L | 1.000 |
| 1:119623089:G:C | F418L | 1.000 |
| 1:119623089:G:T | F418L | 1.000 |
| 1:119623091:A:G | F418L | 1.000 |
| 1:119623173:G:C | F390L | 1.000 |
| 1:119623173:G:T | F390L | 1.000 |
| 1:119623175:A:G | F390L | 1.000 |
| 1:119623257:G:C | F362L | 1.000 |
| 1:119623257:G:T | F362L | 1.000 |
| 1:119623259:A:G | F362L | 1.000 |
| 1:119623449:G:C | F298L | 1.000 |
| 1:119623449:G:T | F298L | 1.000 |
| 1:119623451:A:G | F298L | 1.000 |
| 1:119623506:G:C | H279Q | 1.000 |
| 1:119623506:G:T | H279Q | 1.000 |
| 1:119623508:G:C | H279D | 1.000 |
| 1:119623508:G:T | H279N | 1.000 |
| 1:119623533:G:C | F270L | 1.000 |
| 1:119623533:G:T | F270L | 1.000 |
| 1:119623534:A:G | F270S | 1.000 |
| 1:119623535:A:G | F270L | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000017137 (1:119628067 G>A,C,T), RS1000071970 (1:119628266 T>C), RS1000209155 (1:119630376 C>T), RS1000234723 (1:119642312 G>A), RS1000252699 (1:119622602 G>T), RS1000282753 (1:119629016 C>G), RS1000301032 (1:119622743 T>C), RS1000388104 (1:119648510 A>G), RS1000460290 (1:119648721 T>C), RS1000615532 (1:119641382 A>G), RS1000641503 (1:119624185 C>T), RS1000742770 (1:119647367 T>C), RS1000773838 (1:119647579 C>G), RS1001145602 (1:119628416 A>G), RS1001238595 (1:119647404 G>C,T)
Disease associations
OMIM: gene MIM:620981 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004757_2 | Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis | 3.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB clinical annotations
1 annotations.
| Variant | Type | Level | Drugs | Phenotypes |
|---|---|---|---|---|
| rs10494227 | Efficacy | 3 | interferon beta-1a;interferon beta-1b | Multiple Sclerosis |
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs10494227 | ZNF697 | 3 | 2.50 | 1 | interferon beta-1a;interferon beta-1b |
CTD chemical–gene interactions
43 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression, increases methylation | 3 |
| Acetaminophen | increases expression | 2 |
| Smoke | decreases expression, increases expression | 2 |
| Cyclosporine | increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| FR900359 | decreases phosphorylation | 1 |
| TAK-243 | increases sumoylation | 1 |
| methylmercuric chloride | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases expression | 1 |
| trichostatin A | affects expression | 1 |
| 2,4,5,2’,4’,5’-hexachlorobiphenyl | decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| 3,4,5,3’,4’-pentachlorobiphenyl | decreases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| ferrous chloride | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| ICG 001 | decreases expression | 1 |
| abrine | increases expression | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Allergens | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Calcitriol | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_HD40 | HEK293 eGFP-ZNF697 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): alcohol dependence, alcoholic liver cirrhosis